Executive Summary of the American Radium Society Appropriate Use Criteria for a Multidisciplinary Treatment Approach to the Management of Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma.
Executive Summary of the American Radium Society Appropriate Use Criteria for a Multidisciplinary Treatment Approach to the Management of Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma. Int J Radiat Oncol Biol Phys. 2026 Aug 25.
PMID: 42641667
Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.
Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation. Drugs. 2026 Sep; 86(9):1513-1533.
PMID: 42568026
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 Aug; 24(8).
PMID: 42607715
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation. Ann Oncol. 2026 Oct; 37(10):1437-1449.
PMID: 42270078
Isolated Progression, Systemic Control: Consolidative SBRT in Oligoprogressive MET-Driven NSCLC.
Isolated Progression, Systemic Control: Consolidative SBRT in Oligoprogressive MET-Driven NSCLC. Int J Radiat Oncol Biol Phys. 2026 May 01; 125(1):17.
PMID: 42000356
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 Apr; 24(4).
PMID: 41956107
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study.
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study. Laryngoscope Investig Otolaryngol. 2025 Oct; 10(5):e70246.
PMID: 40995062
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025.
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025. J Natl Compr Canc Netw. 2025 09; 23(9):354-362.
PMID: 40930154
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer.
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer. Clin Cancer Res. 2025 Aug 01; 31(15):3150-3159.
PMID: 40423530
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207].
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207]. Oral Oncol. 2025 Oct; 169:107510.
PMID: 40721367